Evidence map›Paper›PMID 42559566›Full record

ArticleGout, urate, and crystal deposition disease2025

Testing for Causal Association Between Serum Urate, Gout, and Prostatic Cancer in European Males.

Sumanth Chandrupatla, Nicholas Sumpter, Riku Takei, Tony R Merriman, Jasvinder Singh

Abstract read
In one paragraph

Article in Gout, urate, and crystal deposition disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Sumanth ChandrupatlaDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-9522-4020
Nicholas SumpterRadboud University Medical Center, 6525 GA Nijmegen, The Netherlands; nicholas.
Riku TakeiDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-1243-2535
Tony R MerrimanDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Jasvinder SinghDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0003-3485-0006

Funding

Translational genomics in gout: From GWAS signal to mechanismR01AR081859 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TONY R MERRIMAN · 2023 to 2026
$2.3M
NIAMS NIH HHS R01 AR081859
6 · The paper itself

Abstract

We conducted a two-sample Mendelian randomization (MR) study including only European men to test for a causal relationship between serum urate (SU), gout, and prostate cancer. Using genome-wide association (GWAS) data, we generated instrumental variables (IVs) associated with gout and urate. These included 20 single nucleotide polymorphisms (SNPs) associated with gout but not urate (non-hyperuricemia compartment of gout) and four SNPs from loci containing urate transporter genes for an IV representing urate levels. MR methods included the inverse-variance weighted (IVW) method, MR-Egger regression, and the weighted median method. The non-hyperuricemia compartment of gout IV showed a causal effect of gout on prostate cancer (weighted median:

Indexed as

goutprostate cancerurate

Identifiers

PMID42559566
PMCPMC13441251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.